Cortexyme Inc
Biotechnology
Healthcare
CRTX
30.13 M shares
NASDAQ US
traded
13 Sep 2022
listed
yes
open
1.65
52 week high
120.21
high
1.70
52 week low
1.60
low
1.60
growth
-98.29 %
previous Close
1.95
P/E ratio
market cap
89.85 M
div yield
0
usd
Mar 2022
qoq
revenue
0.00 %
net incoming
-21.64 M
75.94 %
eps
0.00 %
7.69 %
eps surprise
-30.91 %
net profit margin
-2164100000.00 %
0.00 %
operating incoming
-21.86 M
75.79 %
net change in cash
-2.16 M
-128.73 %
cash on hand
67.56 M
-3.10 %
cost of revenue
0.00 %
top top